Casdin Capital, LLC’s Structure Therapeutics Inc Position
Does Casdin Capital, LLC own Structure Therapeutics Inc (GPCR)? Yes — 1.18M shares worth $57M (+4.29% of its 13F portfolio) as of Q1 2026.
Position Value
$57M
Q1 2026
Shares
1.18M
% of Portfolio
+4.29%
Quarters Held
13
currently held
Position History GPCR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.18M | $57M | +4.29% |
| Q4 2025 | 1.18M | $82M | +5.08% |
| Q3 2025 | 1.55M | $44M | +3.63% |
| Q2 2025 | 1.23M | $25M | +2.31% |
| Q1 2025 | 700.0K | $12M | +0.99% |
| Q4 2024 | 700.0K | $19M | +1.26% |
| Q3 2024 | 700.0K | $31M | +2.05% |
| Q2 2024 | 700.0K | $27M | +2.11% |
| Q1 2024 | 1.12M | $48M | +3.56% |
| Q4 2023 | 1.09M | $45M | +4.37% |
| Q3 2023 | 1.26M | $62M | +6.86% |
| Q2 2023 | 997.0K | $41M | +3.62% |
| Q1 2023 | 677.0K | $16M | +1.33% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Casdin Capital, LLC’s full portfolio or all institutional holders of GPCR.